Drug Channels Archive for February, 2019

Click a link below to view the mailing archive as if it had been sent to you.

2019-02-28 06:32Drug Channels News Roundup, February 2019: Diplomat's Troubles, Sanofi's Gross-to-Net Bubble, and the Legality of Accumulators
2019-02-26 07:38Drug Channels - The Top 15 U.S. Pharmacies of 2018: M&A Reshapes the Market
2019-02-25 07:33Drug Channels - CBI's 5th Annual Formulary, Copay and Access Summit
2019-02-20 07:48Drug Channels - How Health Plans Profit—and Patients Lose—From Highly-Rebated Brand-Name Drugs
2019-02-19 07:33Drug Channels - CBI's 4th Edition Drug Pricing Transparency Congress
2019-02-15 07:43Drug Channels - Pharmacy Fraud Within Pharmaceutical Co-Pay Programs: What You Need To Know
2019-02-14 07:38Drug Channels - Preorder Now: Our 2019 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers
2019-02-12 07:39Drug Channels - Express Scripts Confirms It (Again): Minimal Growth in Drug Spending and Prescription Costs
2019-02-11 07:39Drug Channels - Expanded Access Programs 2019
2019-02-05 07:42Drug Channels - My Wall Street Journal Op-Ed: Don't Blame Drug Prices on 'Big Pharma'
2019-02-04 07:32Drug Channels - Partnering with IDNs BioPharma Strategy Summit West
2019-02-01 07:37Drug Channels - Shaping an Effective Data and Analytics Strategy for Your Oncology Therapy in 2019


<< Archive IndexSubscribe >>